Cleanroom Technology Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

Cleanroom Technology Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

The Global Clean Room Technology Market was valued at USD 7.53 billion in the previous year, and it is expected to register a CAGR of 4.70%, reaching USD 9.89 billion over the forecast period. The cleanroom technology market has earned some encouraging strides on the back of adopting cleanrooms in manufacturing environments. Regulatory constraints and consumer requirements for better-quality products in these environments have augmented the steady evolution of the market.

There is a growing demand for certified products across various end-user industries. Various quality certifications, like National Safety and Quality Health Standards (NSQHS), ISO checks, etc., have been made mandatory to ensure that the standards for manufacturing processes and manufactured products are upheld.

These quality certifications need products to be processed in a cleanroom environment to ensure minimal contamination. As a result, the global market for cleanroom technology has been witnessing significant growth over the past few years.

Besides the rising demand for certified products, using cleanrooms in the healthcare industry is critical in driving the studied market. Increasing regulatory concerns for improving the quality of healthcare products and ensuring workers’ safety in the industry are the primary reasons behind the growing importance of cleanroom environments in the healthcare industry.

The rapid growth of the healthcare sector in China, India, and other major developing countries offers several opportunities to develop the market studied.

Sectors that demand cleanroom environments made significant manufacturing expansions in 2022, and cleanroom developers have taken part in multimillion-dollar projects for space, pharmaceutical, hi-tech, and industrial production.​

Most builds observed in the pharmaceutical sector in 2022 were in Europe and the United States. For instance, in February 2022, AES Clean Technology, a provider of high-performance cleanroom facilities within the pharmaceutical and biopharmaceutical sector, announced a USD 14.2 million investment to open a new manufacturing facility in Manheim Borough, Pennsylvania. The new advanced facility will be a manufacturing hub for the company’s modular cleanroom systems. As part of the project, AES Clean Technology planned building renovations, purchased the latest production technologies to manufacture its cleanroom products, and trained new employees.

The market studied is projected to benefit from the growth and investments of pharmaceutical CDMOs. For instance, in May 2022, AdvanceTEC, a company operating in cleanroom design, construction, and mission-critical process integration, announced that it had been awarded a large-scale cleanroom design-build contract serving a leading EPCM and biotech CDMO. As a part of the project, AdvanceTEC will leverage its off-site prefabrication and staging facility to enhance scheduling, site logistics, and safety. This facility will be outfitted primarily with CNC, ISO 7 Class 10,000, and localized ISO 5 Class 100 clean spaces.

The Asia-Pacific is also a strategic location for investments in hi-tech applications and expansion of facilities. For instance, in January 2023, Nicomac Taikisha Clean Rooms announced it set up its third manufacturing facility in India. The HVAC and clean room expert plans to invest approximately USD 15 million.

Furthermore, the COVID-19 pandemic enabled a surge in laboratory activities. It forced the activity of sample collections and testing of affected people with the virus, stimulating the demand for consumables in the cleanroom environment.

Cleanroom Technology Market Trends

Pharmaceutical Industry to Witness Significant Growth

The cleanroom technology market has earned some encouraging strides on the back of adopting cleanrooms in manufacturing environments. Regulatory constraints and consumer requirements for better-quality products in these environments have augmented the steady evolution of the market.

The pharmaceutical industry is under continuous development with its research on subcontracting and generic medicines. Therefore, there is a need for stringent cleanroom environment conditions, and to meet these conditions, regulations are tightened.

The adoption of cleanroom technology in the pharmaceuticals industry is expected to grow, owing to the growing manufacturing sectors in countries like the United States, Germany, Vietnam, China, and India. Major trends, such as the growth of private healthcare providers, the expansion of drug manufacturing companies, and the rollout of universal healthcare, are expected to shape the pharmaceutical industry globally.

The pharmaceutical industry has a wide range of complex finished products, which should be protected from contamination, and is critical for the workers and the products in the pharmaceutical industry. There is a dire need for protective clothing for general maintenance and people who work with active pharmaceutical ingredients in cleanroom environments.

Cytotoxic drugs are widely used in the pharmaceutical and healthcare industry. The toxicity of the drugs presents a significant health risk to the manufacturers, pharmacists, and other healthcare industry professionals, who handle these pharmaceutical drugs. Exposure to these drugs is common in their work and can occur differently. In case of exposure to these drugs, a wide range of effects, such as abdominal pain, vomiting, and allergic reactions, can occur. To decrease the risk of exposure, pharmaceutical personnel use protective clothing to handle cytotoxic drugs to ensure safety and the highest levels of protection and maintain a cleanroom environment.

IQVIA estimates global medical spending is expected to increase exponentially and reach USD 1,520 billion by 2023. Owing to such rising demands, the adoption of cleanroom technology in the industry is expected to be augmented during the forecast period.

Moreover, Pharma companies are expanding their presence globally to cater to a wide range of customers and capture a vast market share; such new plant establishments will increase the demand for the studied market. For instance, in October 2022, Aptar Pharma announced expanding and ramping up the Pharma Manufacturing of PremiumCoat ETFE film-coated components and PremiumFill enhanced specification solutions. The first phase of the PremiumCoat capacity expansion is already operational in Granville, France, and includes new ISO7 clean rooms and advanced robotics.

North America to Hold a Significant Market Share

North America accounted for the most significant share, primarily owing to the presence of many medical devices, pharmaceutical manufacturers, and biotechnological labs that are the primary users of cleanroom technology.

Among the countries in North America, the United States occupies a significant share of the market. At the same time, Canada is expected to witness the fastest growth rate in this region over the next five years.

The region is witnessing an increase in investments from government agencies and private organizations to finance the R&D activities of small companies. Initiatives are also taking place at the state level, which is expected to generate the demand for cleanroom technologies.

Talso, for example, the Texas Emerging Technology Fund is explicitly intended to help companies finance proof-of-concept research. The fund finances biological sciences and biotechnology, as well as engineering, materials science, and information technology, and it has committed funding to individual companies with an investment ranging from USD 500,000 to USD 10 million.​

Cleanrooms are classified and regulated by the International Organization for Standardization (ISO) in the United States and Canada by ISO 14644-1. This regulation constitutes cleanroom classes from one to nine, with one having the highest level of cleanliness and nine being the least clean. The most popular classes of cleanroom environments are ISO class 7 and ISO class 8. Advances in the aerospace sector have been a significant source for cleanroom projects, with various governmental and private organizations investing in increased space for satellite production and testing.​

A key sector of the Canadian economy, pharmaceutical companies, are increasingly supported by the government, which offers a business-friendly environment for pharmaceutical companies, which can leverage assets for short and long-term business strategies. The complex manufacturing processes required for certain drugs that require skilled personnel, a stable political environment, and proximity to the end-users of the country are driving the growth of the pharmaceutical CMO market in Canada, in turn driving the Canadian cleanroom technology market.

Cleanroom Technology Industry Overview

The Global Cleanroom Technology Market is competitive. The market is highly concentrated due to the presence of various players. All the players are focusing on expanding their consumer base across the world. Some of the significant players in the market are M+W Group, Azbil Corporation, Clean Rooms International, Kimberly Clark Corporation, Ardmac, Ansell Limited, and many more. The companies are increasing the market share by forming multiple partnerships and investing in introducing new solutions to earn a competitive edge during the forecast period.

In February 2023, Puritas Asgard announced the API facility cleanroom expansion in Singapore. The facility will manufacture APIs critical for critical medications and life-saving drugs. The fully automated plant comprises a general-purpose organic synthesis plant (OSP) incorporating API manufacturing technologies. Moreover, advanced process control systems, business and IT systems, and environmental protection technologies are in place to ensure the optimal running of operations.

In March 2022, MRC Cleanrooms and Biologics Modular allied to offer advanced cleanroom wall system technology to the United States market. These modular wall systems are set to expand the current product matrix for Biologics Modular and provide a strategic position in the United States market for MRC.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support